Intranasal Cobalamin (Cyanocobalamin)

Treatment for Vitamin B12 Deficiency

Typical Dosage: 500 mcg once weekly

Effectiveness
90%
Safety Score
80%
Clinical Trials
20
Participants
1K

Comparative Safety Scale(Higher is safer)

Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
80
DangerousModerateSafe
Treatment Details
Dosage Range
500 mcg once weekly
Time to Effect
Hematologic: 5-7 days; Symptomatic: 1-4 weeks
Treatment Duration
Lifetime for chronic deficiency (maintenance)
Evidence Quality
MODERATE
Confidence Score
75%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$500
Monitoring:$100
Side Effect Mgmt:$20
Total Annual:$620
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
EXCELLENT
ICER
$5,000/QALY
QALYs Gained
0.7
Outcome-Based Costs
Cost per Responder
$688.89
Cost per Remission
$775
Comparison vs Oral Cobalamin
Cost Difference
+$485/year
More expensive
QALY Difference
-0.10 QALYs
Worse outcomes
Dominance
No dominance
Prescription Access Economics
Annual Societal Loss per Patient
$430
Cost of prescription-only barriers (visits, time, admin, price premium)
Physician Visit Cost
$150/year
Time Cost
$50/year
Travel + wait time
Insurance Admin Cost
$30/year
Prior auth, claims
Rx Price
$500/year
Potential OTC Price
$200/year
Estimated if OTC available
Early Treatment Benefit
+0.01 QALYs
From faster OTC access
Risk Assessment
Misuse Risk
LOW
Missed Diagnosis Risk
LOW
Requires Monitoring
Yes
Needs lab work/checkups
Intranasal Cobalamin (Cyanocobalamin) Outcomes

for Vitamin B12 Deficiency

Efficacy Outcomes
Overall Effectiveness
+90%
Response Rate
+90%
Remission Rate
+80%
Common Side Effects
Rhinitis, nasal irritation, headache
+7%
Allergic reactions
+0.05%

Sources:

nih.gov
researchgate.net
nih.gov

WARNING: LIMITED TRIALS AVAILABLE

You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!

FIX IT
Active Clinical Trials
No active trials currently recruiting for this treatment

No active trials found in ClinicalTrials.gov